Correction: Drugmaker dollars story
By APFriday, May 1, 2009
Correction: Drugmaker dollars story
WASHINGTON — In several versions of an April 28 story about a report on the influence of drugmaker money in medicine, The Associated Press reported erroneously that the head of Stanford University’s psychiatry department had stepped down under criticism by a U.S. senator over payments made to him by drugmakers.
Stanford’s Dr. Alan Schatzberg plans not to serve another term as department chairman but remains in the job. The university said Schatzberg had notified it of his intentions before Sen. Charles Grassley questioned Schatzberg’s ties to the pharmaceutical industry in June 2008. Schatzberg and the university deny any links between his plan not to serve another term and drug company ties cited by Grassley.
The story also wrongly characterized Schatzberg’s situation as “similar” to that of an Emory University professor who resigned after Grassley criticized his failure to disclose receiving hundreds of thousands of dollars of drugmaker payments. Schatzberg and Stanford say he made all required disclosures.
